Archive for August 2022

A Bedford-based gene therapy firm is pausing clinical development of one gene therapy to focus on a similar, but potentially broader, treatment. Read More

There are more than 5,400 satellites currently orbiting the Earth, according to the Union of Concerned Scientists, and some of them will inevitably fall back to the surface. One New Hampshire company is working on cleaning up this space junk before it comes crashing down. Read More

Commercial real estate lending volume appears to be slowing as the broader U.S. economy cools off from its pandemic-fueled highs. Read More

The battle over the proposed constitutional amendment to create a 4% surtax on income over $1 million is heating up this week, with a coalition of proponents launching their first TV ad with a pitch to voters that the tax is a “win-win.” Read More

Good morning, Boston. Here are the five most important things you need to know to start your workday, and what Dr. Jill Biden and I have in common. Read More

Most employers are continuing to rely on things like compensation, titles and opportunities for advancement. Those are attractive for many employees, but new research found a segment of untapped talent that’s less interested in those traditional selling points — and may be pivotal to solving long-term talent needs. Read More

Authentic Brands Group, the owner of Boston-based shoe giant Reebok, has struck a deal to acquire British fashion brand Ted Baker London for approximately 211 million pounds, or around $254 million, in an all-cash offer. Read More

The Mass. Gaming Commission has fined Encore Boston Harbor’s Memoire nightclub for serving patrons, some of them underage, more alcohol than they should have been. Read More

Pharma giant Merck & Co. will partner with local startup Orna Therapeutics on multiple vaccines and treatments for infectious diseases and cancer. Read More

A federal judge shot down attempts from the Massachusetts Institute of Technology, Brown University and more than a dozen other elite schools to dismiss a lawsuit accusing them of violating antitrust laws. Read More